Ruconest for Acute HAE Attacks Now Reimbursable in Spain

Ruconest for Acute HAE Attacks Now Reimbursable in Spain

296946

Ruconest for Acute HAE Attacks Now Reimbursable in Spain

Spain has added Ruconest (conestat alfa), Pharming’s treatment for acute attacks of hereditary angioedema (HAE), to its list of reimbursable medications. “We are delighted with this positive reimbursement decision by the Spanish Ministry of Health, as it means patients in Spain in need of new treatment options for hereditary angioedema will now be able to access Ruconest,” Sijmen de Vries, CEO of Pharming, said in a press release. “We look forward to working with the Spanish…

You must be logged in to read/download the full post.